Skip to main content
SpringerLink
Log in

Palliative Treatment of Esophageal Cancer

  • Chapter
  • First Online:
Esophageal Cancer

  • 193 Accesses

Abstract

Esophageal cancer has a rising incidence with many presenting in late stages of disease. Overall prognosis is poor and when unresectable, management focuses on palliation of symptoms and improving quality of life. Patients with locally advanced esophageal cancer most commonly presents with dysphagia, weight loss and pain. There are various modalities used for alleviation of symptoms including chemoradiation, endoluminal stenting, brachytherapy and other ablative techniques. Each option has associated risks and benefits. Patient performance status should be taken into account and choice of approach should be individualized with the aid of a multidisciplinary care team.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:855–83. https://doi.org/10.6004/jnccn.2019.0033

  2. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am. 2012;92:1077–87. https://doi.org/10.1016/j.suc.2012.07.008

  3. Diamantis G, et al. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol. 2011;17:144–50. https://doi.org/10.3748/wjg.v17.i2.144

  4. Sun L, Quan XQ, Yu S. An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status. Nutr Cancer. 2015;67:1056–62. https://doi.org/10.1080/01635581.2015.1073753

  5. Okawa T, Kita M, Tanaka M, Ikeda M. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1989;17:49–54. https://doi.org/10.1016/0360-3016(89)90369-6

  6. Newaishy GA, Read GA, Duncan W, Kerr GR. Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol. 1982;33:347–52. https://doi.org/10.1016/s0009-9260(82)80288-2

  7. Herskovic A, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–8. https://doi.org/10.1056/NEJM199206113262403

  8. Minsky BD, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–74. https://doi.org/10.1200/JCO.2002.20.5.1167

  9. Kachnic LA, et al. Longitudinal quality-of-life analysis of RTOG 94-05 (Int 0123): a phase III trial of definitive chemoradiotherapy for esophageal cancer. Gastrointest Cancer Res. 2011;4:45–52.

    PubMed  PubMed Central  Google Scholar 

  10. Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21:393–422. https://doi.org/10.6004/jnccn.2023.0019

  11. al-Sarraf M, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277–84. https://doi.org/10.1200/JCO.1997.15.1.277

  12. van Rossum PSN, Mohammad NH, Vleggaar FP, van Hillegersberg R. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nat Rev Gastroenterol Hepatol. 2018;15:235–49. https://doi.org/10.1038/nrgastro.2017.162

  13. Janmaat VT, et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063. https://doi.org/10.1002/14651858.CD004063.pub4

  14. Harvey JA, et al. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Dis Esophagus. 2004;17:260–5. https://doi.org/10.1111/j.1442-2050.2004.00420.x

  15. Ueda H, et al. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer. Oncotarget. 2017;8:80286–94. https://doi.org/10.18632/oncotarget.17925

  16. Coia LR, Soffen EM, Schultheiss TE, Martin EE, Hanks GE. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer. 1992;71:281–6. https://doi.org/10.1002/1097-0142(19930115)71:2<281::aid-cncr2820710202>3.0.co;2-0

  17. Standards of Practice C, et al. Esophageal dilation. Gastrointest Endosc. 2006;63:755–60. https://doi.org/10.1016/j.gie.2006.02.031

  18. Mocanu A, Barla R, Hoara P, Constantinoiu S. Endoscopic palliation of advanced esophageal cancer. J Med Life. 2015;8:193–201.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Chen HL, Shen WQ, Liu K. Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2017;30:1–16. https://doi.org/10.1093/dote/dow010

  20. Spaander MCW, et al. Esophageal stenting for benign and malignant disease: European society of gastrointestinal endoscopy (ESGE) guideline—update 2021. Endoscopy. 2021;53:751–62. https://doi.org/10.1055/a-1475-0063

  21. Halpern AL, McCarter MD. Palliative management of gastric and esophageal cancer. Surg Clin North Am. 2019;99:555–69. https://doi.org/10.1016/j.suc.2019.02.007

  22. Spaander MC, et al. Esophageal stenting for benign and malignant disease: European society of gastrointestinal endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48:939–48. https://doi.org/10.1055/s-0042-114210

  23. Battaglia G, et al. Feasibility, efficacy and safety of stent insertion as a palliative treatment for malignant strictures in the cervical segment of the esophagus and the hypopharynx. Surg Endosc. 2016;30:159–67. https://doi.org/10.1007/s00464-015-4176-z

  24. Martin EJ, et al. Palliative radiotherapy versus esophageal stent placement in the management of patients with metastatic esophageal cancer. J Natl Compr Canc Netw. 2020;18:569–74. https://doi.org/10.6004/jnccn.2019.7524

  25. Vermeulen BD, Siersema PD. Esophageal stenting in clinical practice: an overview. Curr Treat Options Gastroenterol. 2018;16:260–73. https://doi.org/10.1007/s11938-018-0181-3

  26. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447–53. https://doi.org/10.1016/s0360-3016(97)00710-4

  27. Homs MY, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364:1497–504. https://doi.org/10.1016/S0140-6736(04)17272-3

  28. Gaspar LE, et al. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Int J Radiat Oncol Biol Phys. 1997;37:593–9. https://doi.org/10.1016/s0360-3016(96)00591-3

  29. Eickhoff A, et al. Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC. Endoscopy. 2007;39:637–42. https://doi.org/10.1055/s-2007-966571

  30. Sigounas DE, et al. Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer. United Eur Gastroenterol J. 2017;5:21–31. https://doi.org/10.1177/2050640616650786

  31. Heindorff H, Wojdemann M, Bisgaard T, Svendsen LB. Endoscopic palliation of inoperable cancer of the oesophagus or cardia by argon electrocoagulation. Scand J Gastroenterol. 1998;33:21–3. https://doi.org/10.1080/00365529850166158

  32. Kachaamy T, et al. Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer. Gastrointest Endosc. 2018;88:447–55. https://doi.org/10.1016/j.gie.2018.04.2362

  33. Coffey MR, et al. Palliative surgery outcomes for patients with esophageal cancer: an national cancer database analysis. J Surg Res. 2021;267:229–34. https://doi.org/10.1016/j.jss.2021.05.013

  34. Takeno S, et al. Drainage tubeless (DRESS) bypass surgery as the best palliative care for unresectable thoracic esophageal cancer with and without esophago-respiratory fistula. Ann Thorac Cardiovasc Surg. 2019;25:82–6. https://doi.org/10.5761/atcs.oa.18-00170

Download references

Author information

Authors and Affiliations

  1. NorthShore University HealthSystem, Evanston, USA

    Simon Y. W. Che & Michael B. Ujiki

Authors
  1. Simon Y. W. Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael B. Ujiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael B. Ujiki .

Editor information

Editors and Affiliations

  1. Hospital Alemán of Buenos Aires, University of Buenos Aires, Buenos Aires, Argentina

    Francisco Schlottmann

  2. Department of Surgery and Oncology, McGill University, Montreal, QC, Canada

    Lorenzo Ferri

  3. Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Daniela Molena

  4. Department of Surgery, University of Virginia, Charlottesville, VA, USA

    Marco G. Patti

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Che, S.Y.W., Ujiki, M.B. (2023). Palliative Treatment of Esophageal Cancer. In: Schlottmann, F., Ferri, L., Molena, D., Patti, M.G. (eds) Esophageal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-39086-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-39086-9_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-39085-2

  • Online ISBN: 978-3-031-39086-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation